The plasma homocysteine levels are increased in polycystic ovary syndrome

Gynecologic and Obstetric Investigation

Volumn 53, Issue 3, 2002, Pages 157-162

  Loverro, Giuseppe ^a   Lorusso, Filomenamila ^a   Mei, Loredana ^a   Depalo, Raffaella ^a   Cormio, Gennaro ^a   Selvaggi, Luigi ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Cardiovascular diseases; Insulin resistance; Lipids; Plasma homocysteine; Polycystic ovary syndrome

Indexed keywords

HOMOCYSTEINE; INSULIN; LIPID;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION TEST; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; ULTRASOUND;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; LIPIDS; POLYCYSTIC OVARY SYNDROME; RISK FACTORS;

EID: 0036278093     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058367     Document Type: Article

References (41)

1. The importance of diagnosing the polycystic ovary syndrome
2. Polycystic ovary syndrome
3. Polycystic ovary syndrome: New prospective on an old problem
4. Insulin resistance, compensatory hyperinsulinemia, and coronary artery disease
5. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries
6. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity
7. An alternative view of homocysteine
8. Homocysteine and cardiovascular disease
9. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects
10. Insulin secretion as a potential determinant of homocysteine levels
11. Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotropin releasing hormone
12. Ultrasono-graphic identification of polycystic ovary
13. Hirsutism: Implications, etiology and management
14. Cortisol and estradiol: Nongenetic factors for hyperhomocysteinemia
15. Pathophysiology of insulin resistance in human disease
16. Hyperinsulinemia as an independent risk factor for ischemic heart disease
17. Insulin and risk of cardiovascular disease: A meta-analysis
18. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
19. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
20. Polycystic ovarian disease: Heritability and heterogeneity
21. Polycystic ovaries are inherited as an autosomal dominant trait: Analysis of 29 polycystic ovary syndrome and 10 control families
22. C677T (thermolabile alanine/valine) polymorphism in methylene-tetrahydrofolate reductase (MTHFR): Its frequency and impact on plasma homocysteine concentrations in different European populations (EARS group)
23. Homocysteine plasma levels are independently associated with insulin resistance in normal weight, overweight and obese premenopausal women
24. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal
25. Plasma total homocysteine levels in subjects with hyperinsulinemia
26. Increased risk of non-insulin-dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome
27. Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women
28. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization
29. Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study
30. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: Results of a case-control study
31. Polycystic ovarian syndrome and thrombophilia
32. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome
33. Plasma homocysteine, fasting insulin, and androgen patterns among women with polycystic ovaries and infertility
34. Changes of plasma total homocysteine levels during the menstrual cycle
35. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects
36. Total homocysteine in plasma and amniotic fluid of pregnant women
37. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects
38. Insulin is an independent correlate of plasma homocysteine level in obese children and adolescents
39. Hyperhomocysteinemia is associated with carotid atherosclerosis
40. Homocysteine and atherosclerosis disease
41. Hyperhomocysteinemia in type 2 diabetes mellitus: Cardiovascular risk factors and effect of treatment with folic acid and pyridoxine